新型精準放射治療減少攝護腺癌患者回診次數
New precision radiotherapy cuts hospital visits for prostate cancer patients
Updated at: June 10, 2026 at 06:00 AM
醫學技術在對抗攝護腺癌方面已達到重要的里程碑。
Medical technology has reached a significant milestone in the fight against prostate cancer.
一種被稱為「分割放射治療」(hypofractionated radiotherapy)的現代方法已成為新的照護標準，徹底改變了病患的就醫體驗。
A modern approach called hypofractionated radiotherapy has emerged as a new standard of care, transforming the patient experience.
如今，精準成像與線性加速器的進步，讓醫生能夠在少得多的療程中提供更高、更具標靶性的放射劑量，有時甚至短至五週或更短。
Today, advancements in precision imaging and linear accelerators allow doctors to deliver higher, more targeted doses of radiation in far fewer sessions, sometimes as few as five weeks or less.
這項創新是效率的勝利。
This innovation is a triumph of efficiency.
臨床試驗已證實，這種較短的療程與傳統方法一樣安全且有效，在不增加長期副作用的情況下，提供了等效的癌症控制。
Clinical trials have confirmed that this shorter course is just as safe and effective as traditional methods, providing equivalent cancer control without increasing long-term side effects.
除了臨床成功之外，這對生活品質的影響也很深遠。
Beyond the clinical success, the impact on quality of life is profound.
雖然每個治療計畫仍採個人化，但引進分割放射治療代表著重大的躍進，證明醫學的進步不僅在於新的發現，更在於讓現有的救命治療對需要的人來說更加容易獲取且更便利。
While every treatment plan remains personalized, the adoption of hypofractionation represents a major leap forward, proving that medical progress is not just about new discoveries, but also about making existing, life-saving treatments more accessible and convenient for those who need them.
